Global Lead of Health Financing, Technologies, Data, and Impact
Héctor Castro, MD, PhD, Global Lead of Infectious Diseases, Health Financing, Technologies, Data, and Impact at MSH, has more than 20 years of global health experience with a focus on health systems strengthening and reforms in quality assurance, assessment, health financing, strategic purchasing, and provision of health care services and technologies (including medicines, devices, and procedures) in low and middle-income countries. Before joining MSH, Dr. Castro served as chief officer, technical advisor, director, and manager in strategic planning, quality assurance, health, safety, and environment for various pharmaceutical, health insurance, and nongovernmental organizations.
Dr. Castro is currently the Latin America Policy Forum Chair of the Health Technology Assessment International (HTAi), former founding Chief Executive Director of the HTA Institute of Colombia, and Director of Medicines and Technologies at the Ministry of Health and Social Protection of Colombia. He served from 2018 to 2020 on the Board of Directors of HTAi, a prominent international network in the field of health technology assessment. Dr. Castro is a physician by training, has an MSc in Health Policy, Planning, and Financing from the London School of Economics and Political Science, is a Doctor in Public Health and Policy/Health Economics from the London School of Hygiene and Tropical Medicine, and was a Takemi Postdoctoral Fellow at the Harvard T.H. Chan School of Public Health.